RNS Number : 0291L
Arcontech Group PLC
08 September 2021
 

 

ARCONTECH GROUP PLC

 

Exercise of Options

 

Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading, announces the exercise of share options by an employee of the Company over 20,000 new ordinary shares of 12.5 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 64.5 pence per share.

 

Application has been made to the London Stock Exchange for the 20,000 new Ordinary Shares to be admitted to trading on AIM and admission is expected to occur on or around 8.00am 14 September 2021. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue.

 

Total Voting Rights

 

For the purpose of the Disclosure Guidance and Transparency Rules, following the above issue of equity, the issued share capital of the Company will comprise 13,372,811 Ordinary Shares. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

Arcontech Group plc

020 7256 2300

Geoff Wicks, Chairman and Non-Executive Director


Matthew Jeffs, Chief Executive




finnCap Ltd (Nomad & Broker)

020 7220 0500

Carl Holmes/Tim Harper

Harriet Ward - ECM




To access more information on the Group please visit: www.arcontech.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEAKNXEEFFEFA